Showing results (51-60 of 126) with videos related to
Sort By:
Pageof 13
Annals of the New York Academy of Sciences|January 1, 1990
Prostate long-term epithelial cell lines. Biological and biochemical featuresL Castagnetta, G Carruba, O M Granata, et al.The Journal of Urology|April 1, 1989
Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trialsH J de Voogt, S Suciu, R Sylvester, et al.Pathology, Research and Practice|November 1, 1989
Morphometry of in vitro systems. An image analysis of two human prostate cancer cell lines (PC3 and DU-145)G Carruba, C Pavone, M Pavone-Macaluso, et al.European Urology|April 15, 2000
Correlation between chronic prostatitis syndrome and pelvic venous disease: a survey of 2,554 urologic outpatientsC Pavone, E Caldarera, P Liberti, et al.The Journal of Urology|December 1, 1992
A European Organization for Research and Treatment of Cancer--Genitourinary Group phase 2 study of chemotherapy in stage T3-4N0-XM0 transitional cell cancer of the bladder: evaluation of clinical responseT A Splinter, M Pavone-Macaluso, D Jacqmin, et al.The Journal of Urology|September 1, 1986
Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological GroupM Pavone-Macaluso, H J de Voogt, G Viggiano, et al.European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Genitourinary group phase II study of chemotherapy in stage T3-4 N0-X M0 transitional cell cancer of the bladder: prognostic factor analysisT A Splinter, M Pavone-Macaluso, D Jacqmin, et al.European Urology|January 1, 1992
Intravesical therapy of superficial bladder transitional cell carcinoma with tumor necrosis factor-alpha: preliminary report of a phase I-II studyV Serretta, G Corselli, B Piazza, et al.Urological Research|January 1, 1994
Androgen receptors and hormone sensitivity of a human prostatic cancer cell line (PC-3) are modulated by natural beta-interferonG Sica, G Dell'Acqua, F Iacopino, et al.Steroids|July 1, 1994
Steroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cellsG Carruba, R E Leake, F Rinaldi, et al.Pageof 13